Evidence map›Paper›PMID 38903675›Full record

ArticleRSC advances2024

Acid-base responsive molecular switching of a [2]rotaxane incorporating two different stations in an axle component.

Risa Yamane, Yuki Asai, Nanami Takiguchi, Ayuna Okamoto, Shintaro Kawano, Yuji Tokunaga, Motohiro Shizuma, Masahiro Muraoka

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Risa YamaneDepartment of Applied Chemistry, Faculty of Engineering, Osaka Institute of Technology Asahi-ku Osaka 535-8585 Japan masahiro.muraoka@oit.ac.jp.
Yuki AsaiDepartment of Applied Chemistry, Faculty of Engineering, Osaka Institute of Technology Asahi-ku Osaka 535-8585 Japan masahiro.muraoka@oit.ac.jp.
Nanami TakiguchiDepartment of Applied Chemistry, Faculty of Engineering, Osaka Institute of Technology Asahi-ku Osaka 535-8585 Japan masahiro.muraoka@oit.ac.jp.
Ayuna OkamotoDepartment of Applied Chemistry, Faculty of Engineering, Osaka Institute of Technology Asahi-ku Osaka 535-8585 Japan masahiro.muraoka@oit.ac.jp.
Shintaro KawanoOsaka Research Institute of Industrial Science and Technology Joto-ku Osaka 536-8553 Japan.ORCID https://orcid.org/0000-0003-4239-7109
Yuji TokunagaDepartment of Materials Science and Engineering, Faculty of Engineering, University of Fukui Bunkyo Fukui 910-8507 Japan.ORCID https://orcid.org/0000-0002-4183-7320
Motohiro ShizumaOsaka Research Institute of Industrial Science and Technology Joto-ku Osaka 536-8553 Japan.ORCID https://orcid.org/0000-0002-8682-7660
Masahiro MuraokaDepartment of Applied Chemistry, Faculty of Engineering, Osaka Institute of Technology Asahi-ku Osaka 535-8585 Japan masahiro.muraoka@oit.ac.jp.ORCID https://orcid.org/0000-0002-4945-0761

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interlocked compounds such as rotaxanes and catenanes exhibit unique kinetic properties in response to external chemical or physical stimuli and are therefore expected to be applied to molecular machines and molecular sensors. To develop a novel rotaxane for this application, an isophthalamide macrocycle and a neutral phenanthroline axle were used. Stable pseudorotaxanes are known to be formed using hydrogen bonds and π-π interactions. In this study, we designed a non-symmetric axial molecule and synthesized a [2]rotaxane with the aim of introducing two different stations; a phenanthroline and a secondary amine/ammonium unit. Furthermore,

Identifiers

PMID38903675
PMCPMC11188621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.